Valsartan/hydrochlorothiazide
Valsartan/hydrochlorothiazide, sold under the brand name Diovan HCT among others, is an medication used to treat high blood pressure when valsartan is not sufficient.[3] It is a combination of valsartan, an angiotensin receptor blocker with hydrochlorothiazide, a diuretic.[4] It is taken by mouth.[4]
Combination of | |
---|---|
Valsartan | Angiotensin II receptor antagonist |
Hydrochlorothiazide | Thiazide diuretic |
Clinical data | |
Trade names | Co-vasotec, Diovan HCT, Co-Diovan, others |
AHFS/Drugs.com | Professional Drug Facts |
MedlinePlus | a611032 |
License data | |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
PubChem CID | |
KEGG | |
CompTox Dashboard (EPA) | |
(verify) |
Common side effects include dizziness and headaches.[4] Serious side effects may include allergic reactions, electrolyte abnormalities, and glaucoma.[1] Use in pregnancy is not recommended.[1]
The combination was approved for medical use in the United States in 1998.[4] It is available as a generic medication.[3] In 2017, it was the 133rd most commonly prescribed medication in the United States, with more than five million prescriptions.[5][6]
References
- "Diovan HCT- valsartan and hydrochlorothiazide tablet, film coated". DailyMed. Retrieved 20 January 2021.
- https://www.ema.europa.eu/documents/psusa/valsartan-hydrochlorothiazide/valsartan-list-nationally-authorised-medicinal-products-psusa/00010396/202004_en.pdf
- British national formulary : BNF 76 (76 ed.). Pharmaceutical Press. 2018. p. 179. ISBN 9780857113382.
- "Hydrochlorothiazide and valsartan Uses, Side Effects & Warnings". Drugs.com. Retrieved 10 March 2019.
- "The Top 300 of 2020". ClinCalc. Retrieved 11 April 2020.
- "Hydrochlorothiazide; Valsartan - Drug Usage Statistics". ClinCalc. Retrieved 11 April 2020.
External links
- "Hydrochlorothiazide mixture with valsartan". Drug Information Portal. U.S. National Library of Medicine.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.